GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.

"I think I was never afraid of the next decade or the next year," the star tells PEOPLE on set of GSK's Thrive@50+ campaign ...

Details: Keith Heigel, with Light-Heigel & Associates, who presented the plan, said the expansion would bring about 150 jobs ...

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would ...

GSK reached a settlement with plaintiff Isaac Dixon, resolving a case related to its discontinued heartburn medicine Zantac allegedly causing prostate cancer, filed in Illinois State court.

British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...

PRESS RELEASECHARM Therapeutics appoints Dr Beverley Carr as Chief Business OfficerHighly experienced dealmaker to lead CHARM ...

It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025. The team ...

Jobs in the financial sector can be highly lucrative, which helps explain why they’re in such great demand. Of course, breaking into the world of finance isn’t easy—the entry qualifications ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 25 shareholders Insiders have been ...